Bronte Capital Management Pty Ltd. Buys General Mills Inc, Philip Morris International Inc, Sotera Health Co, Sells BioNTech SE

Investment company

Bronte Capital Management Pty Ltd. (Current Portfolio) buys General Mills Inc, Philip Morris International Inc, Sotera Health Co, Bath & Body Works Inc, Vir Biotechnology Inc, sells BioNTech SE during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Bronte Capital Management Pty Ltd.. As of 2021Q3, Bronte Capital Management Pty Ltd. owns 27 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

• New Purchases: GIS, PM, SHC, BBWI, VIR, NPO,
• Added Positions: REGN, HLF, CTVA, GHC, IBKR, MDLZ,
• Reduced Positions: BRK.B, BNTX,

For the details of Bronte Capital Management Pty Ltd.'s stock buys and sells, go to https://www.gurufocus.com/guru/bronte+capital+management+pty+ltd./current-portfolio/portfolio

These are the top 5 holdings of Bronte Capital Management Pty Ltd.

1. iShares Russell 2000 ETF (IWM) - 156,100 shares, 25.18% of the total portfolio.
2. S&P 500 ETF TRUST ETF (SPY) - 42,400 shares, 13.36% of the total portfolio.
3. iShares Russell 2000 Growth ETF (IWO) - 462,700 shares, 9.94% of the total portfolio.
4. Alphabet Inc (GOOGL) - 49,176 shares, 9.62% of the total portfolio.
5. Berkshire Hathaway Inc (BRK.B) - 416,558 shares, 8.32% of the total portfolio. Shares reduced by 1.75%

New Purchase: General Mills Inc (GIS)

Bronte Capital Management Pty Ltd. initiated holding in General Mills Inc. The purchase prices were between $56.79 and $60.86, with an estimated average price of $59.09. The stock is now traded at around $63.170000. The impact to a portfolio due to this purchase was 0.74%. The holding were 168,870 shares as of 2021-09-30.

New Purchase: Philip Morris International Inc (PM)

Bronte Capital Management Pty Ltd. initiated holding in Philip Morris International Inc. The purchase prices were between $94.79 and $106.1, with an estimated average price of $100.67. The stock is now traded at around $93.767500. The impact to a portfolio due to this purchase was 0.74%. The holding were 106,293 shares as of 2021-09-30.

New Purchase: Sotera Health Co (SHC)

Bronte Capital Management Pty Ltd. initiated holding in Sotera Health Co. The purchase prices were between $22.25 and $26.52, with an estimated average price of $24.22. The stock is now traded at around $27.230000. The impact to a portfolio due to this purchase was 0.34%. The holding were 179,279 shares as of 2021-09-30.

New Purchase: Bath & Body Works Inc (BBWI)

Bronte Capital Management Pty Ltd. initiated holding in Bath & Body Works Inc. The purchase prices were between $56.59 and $69.03, with an estimated average price of $63.54. The stock is now traded at around $75.340000. The impact to a portfolio due to this purchase was 0.28%. The holding were 59,794 shares as of 2021-09-30.

New Purchase: Vir Biotechnology Inc (VIR)

Bronte Capital Management Pty Ltd. initiated holding in Vir Biotechnology Inc. The purchase prices were between $34.9 and $54.54, with an estimated average price of $43.35. The stock is now traded at around $32.550000. The impact to a portfolio due to this purchase was 0.24%. The holding were 74,920 shares as of 2021-09-30.

New Purchase: EnPro Industries Inc (NPO)

Bronte Capital Management Pty Ltd. initiated holding in EnPro Industries Inc. The purchase prices were between $80.5 and $97.28, with an estimated average price of $87.89. The stock is now traded at around $105.220000. The impact to a portfolio due to this purchase was 0.19%. The holding were 30,000 shares as of 2021-09-30.

Here is the complete portfolio of Bronte Capital Management Pty Ltd.. Also check out:

1. Bronte Capital Management Pty Ltd.'s Undervalued Stocks
2. Bronte Capital Management Pty Ltd.'s Top Growth Companies, and
3. Bronte Capital Management Pty Ltd.'s High Yield stocks
4. Stocks that Bronte Capital Management Pty Ltd. keeps buying